OCT 19, 2017 8:00 AM PDT

WEBINAR: New viral and non-viral platforms for T-cell engineering

Speaker

Abstract

DATE: October 19, 2017
TIME: 08:00am PDT, 11:00am EDT

 

Recent FDA approval of the first Chimeric Antigen Receptor T cell (CAR-T) therapy offers cancer patients more promise than ever for curative effects. However, many technical challenges in T cell gene delivery still remain in order for this therapy to become a standard of care practice. In this webinar, we will highlight the different viral and non-viral delivery approaches used in T cell engineering for cell and gene therapy applications including:

  • New solution for small-to-large scale serum-free, suspension lentiviral production – LV-MAX™ Lentiviral Production System
    • Platform development process using Design of Experiment (DOE) methodologies
    • High-throughput to large scale bioreactor protocols
    • Cost benefits of this system over current methods
  • Novel gene editing tools for primary T cells
    • New potent gene editing tools to increase knock-in and knock-out efficiency
    • Addressing non-viral delivery barriers through protocol optimization

Learning Objectives:

  • Current industry trends and challenges of cell and gene therapy manufacturing
  • Benefits of innovative new upstream technologies for virus generation in suspension

Show Resources
You May Also Like
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
JUL 15, 2021 9:00 AM PDT
JUL 15, 2021 9:00 AM PDT
Date: July 15, 2021 Time: 9:00am (PDT), 12:00pm (EDT) The Pisces workflow robust, easy-to-use, end-to-end multi-omics solution for highly multiplexed targeted Spatial RNA analysis. VeranomeB...
JUN 03, 2021 12:00 PM CST
JUN 03, 2021 12:00 PM CST
DATE: June 3, 2021 TIME: 12:00pm SGT This webinar is a virtual event that focuses on utilizing the Gibco CTS Rotea System for Cell and Gene Therapy...
JUL 15, 2021 8:00 AM PDT
C.E. CREDITS
JUL 15, 2021 8:00 AM PDT
Date: July 15, 2021 Time: 8:00am (PDT), 11:00am (EDT) High dimensional full spectrum flow cytometry grants unprecedented access to previously unattainable parameters in cellular biology. Flu...
OCT 19, 2017 8:00 AM PDT

WEBINAR: New viral and non-viral platforms for T-cell engineering


Specialty

Cancer Research

Immunology

Cell Biology

Cancer Therapeutics

Molecular Biology

Biotechnology

Cell Culture

Oncology

Cancer Diagnostics

Biomarkers

Immuno-Oncology

Gene Expression

Genetics

Clinical Research

Drug Discovery

Geography

North America56%

Europe28%

Asia6%

South America3%

Oceania2%

Africa2%

Registration Source

Website Visitors100%

Job Title

Student17%

Scientist15%

Research Scientist12%

Executive12%

Facility/Department Manager11%

Medical Doctor/Specialist6%

Post Doc5%

Medical Laboratory Technician4%

Educator/Faculty3%

Marketing/Sales3%

Clinical Laboratory Scientist3%

Lab Management2%

Engineer2%

QC/QA2%

Biologist2%

Chemist1%

Consultant1%

Organization

Academic Institution9%

Biotech Company8%

Research Institute5%

Clinical Laboratory4%

Life Science Company3%

Hospital3%

Government2%

Pharmaceutical Company2%

Medical Center1%

Ambulatory Care1%

Consultant1%

Contract Research Organization (Cro)1%

Industrial Company1%

Medical School1%

Other2%


Show Resources
Loading Comments...
Show Resources